Rafal Wierzbicki

Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study

Charles S. Fuchs, John L. Marshall, Edith P. Mitchell et al. · Journal of Clinical Oncology · 2007 · 854 citations

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

Robert L. Souhami, Alan Craft, Jan W. van der Eijken et al. · The Lancet · 1997 · 381 citations

Surgical Oncology, Medicine, Cancer Management +9

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial

Cesare Gridelli, Fortunato Ciardiello, Ciro Gallo et al. · Journal of Clinical Oncology · 2012 · 232 citations · Full text

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial

Giorgio V. Scagliotti, Maciej Krzakowski, Aleksandra Szczęsna et al. · Journal of Clinical Oncology · 2012 · 211 citations

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

Peter Ellis, Frances A. Shepherd, Michael Millward et al. · The Lancet Oncology · 2014 · 125 citations

Pretreated Patients, Oncology, Ncic Ctg Br.26 +9